Encompass Health Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Mark Tarr
Chief executive officer
US$8.8m
Total compensation
| CEO salary percentage | 11.9% |
| CEO tenure | 8yrs |
| CEO ownership | 0.5% |
| Management average tenure | 11.3yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors
Dec 10
Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings
Oct 21Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$432m |
| Jun 30 2024 | n/a | n/a | US$409m |
| Mar 31 2024 | n/a | n/a | US$387m |
| Dec 31 2023 | US$9m | US$1m | US$362m |
| Sep 30 2023 | n/a | n/a | US$357m |
| Jun 30 2023 | n/a | n/a | US$336m |
| Mar 31 2023 | n/a | n/a | US$280m |
| Dec 31 2022 | US$8m | US$1m | US$256m |
| Sep 30 2022 | n/a | n/a | US$232m |
| Jun 30 2022 | n/a | n/a | US$242m |
| Mar 31 2022 | n/a | n/a | US$253m |
| Dec 31 2021 | US$8m | US$1m | US$298m |
| Sep 30 2021 | n/a | n/a | US$316m |
| Jun 30 2021 | n/a | n/a | US$318m |
| Mar 31 2021 | n/a | n/a | US$304m |
| Dec 31 2020 | US$7m | US$953k | US$193m |
| Sep 30 2020 | n/a | n/a | US$265m |
| Jun 30 2020 | n/a | n/a | US$285m |
| Mar 31 2020 | n/a | n/a | US$342m |
| Dec 31 2019 | US$7m | US$1m | US$358m |
| Sep 30 2019 | n/a | n/a | US$317m |
| Jun 30 2019 | n/a | n/a | US$308m |
| Mar 31 2019 | n/a | n/a | US$309m |
| Dec 31 2018 | US$6m | US$963k | US$290m |
| Sep 30 2018 | n/a | n/a | US$339m |
| Jun 30 2018 | n/a | n/a | US$316m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$5m | US$900k | US$271m |
Compensation vs Market: Mark's total compensation ($USD8.84M) is about average for companies of similar size in the US market ($USD8.04M).
Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.
CEO
Mark Tarr (62 yo)
8yrs
Tenure
US$8,836,376
Compensation
Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8yrs | US$8.84m | 0.55% $ 52.3m | |
| Executive VP & CFO | 14.6yrs | US$5.75m | 0.26% $ 24.7m | |
| Senior VP & Chief Accounting Officer | 15.2yrs | US$1.10m | 0.076% $ 7.2m | |
| Executive VP | 8.8yrs | US$3.17m | 0.084% $ 8.0m | |
| Chief Medical Officer | 9.4yrs | US$1.30m | 0.018% $ 1.8m | |
| Chief Information Officer & Senior VP | 13.4yrs | no data | no data | |
| Senior Vice President of Investor Relations & Strategic Planning | 3.3yrs | no data | no data | |
| Chief Compliance Officer | 9.4yrs | no data | no data | |
| Chief Human Resources Officer | 4.9yrs | no data | no data | |
| President of Southwest Region | 13.3yrs | no data | no data | |
| President of West Region | 13.3yrs | no data | no data | |
| President of Northeast Region | 16.5yrs | no data | no data |
11.3yrs
Average Tenure
60.5yo
Average Age
Experienced Management: EHC's management team is seasoned and experienced (11.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8yrs | US$8.84m | 0.55% $ 52.3m | |
| Independent Director | 11.9yrs | US$289.80k | 0.00099% $ 94.2k | |
| Independent Director | 11.9yrs | US$294.80k | 0.00099% $ 94.2k | |
| Independent Director | 7yrs | US$259.79k | 0.000040% $ 3.8k | |
| Independent Chairman | 4.9yrs | US$276.01k | 0.0038% $ 361.6k | |
| Independent Director | 4.9yrs | US$256.01k | 0.000020% $ 1.9k | |
| Independent Director | 3.2yrs | US$272.98k | 0.012% $ 1.2m | |
| Director | 1.1yrs | US$74.45k | 0.00049% $ 46.6k | |
| Independent Director | 2.8yrs | US$252.54k | 0.0010% $ 95.2k | |
| Independent Director | 4.9yrs | US$271.01k | 0.00035% $ 33.3k |
4.9yrs
Average Tenure
64.5yo
Average Age
Experienced Board: EHC's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:08 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Encompass Health Corporation is covered by 38 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null RESEARCH DEPARTMENT | Avondale Partners |
| Matthew Gillmor | Baird |
| Ishan Majumdar | Baptista Research |